Progress in Drug Research

Progress in Drug Research

by Paul A. KeiferQ.May Wang Angelo Vedani and others
Epub (Kobo), Epub (Adobe)
Publication Date: 29/12/2015

Share This eBook:

  $76.99

Hepatitis C virus (HCV) was first identified in 1989 as the etiologic agent of non-A, non-B hepatitis [1] and is currently recognized as the leading cause of chronic liver disease worldwide. In contrast to hepatitis B virus infection, in which only about 5% of adult infections become chronic, more than 80% of HCV-infected patients develop chronic hepatitis. Moreover, 20-50% of those persistently infected with HCV will develop liver cirrhosis and hepatocellu lar carcinoma (HCC) [2]. It is estimated that there are 10,000 deaths in the USA per year due to chronic liver failure or HCC [3]. In addition, HCV dis 25-50% of all liver transplants in US centers, and the ease is responsible for recurrence of HCV infection following liver transplantation is universal [4]. Typically, HCV disease emerges after a 10-20 year period during which symp toms, if they exist at all, are mild and non-specific. Although the prevalence varies greatly among different countries, it has been estimated that up to 170 million people (3% of the world's population), are infected with HCV [5]. A recent study in the USA found that 65% of all HCV-infected persons are 30 to 49 years old [6].

ISBN:
9783034883856
9783034883856
Category:
Medicine
Format:
Epub (Kobo), Epub (Adobe)
Publication Date:
29-12-2015
Language:
English
Publisher:
Birkhäuser Basel

This item is delivered digitally

Reviews

Be the first to review Progress in Drug Research.